We report the characterization of two vertebrate homologs of Drosophila mothers against dpp (Mad) isolated from the mouse and the Xenopus embryo, named MusMLP (mad-like protein) and XenMLP. respectively, together with a summary of their expression patterns in the embryo. Overexpression of XenMLP causes ventralization of Xenopus embryos and we demonstrate that the C-terminal domain is necessary and sufficient to confer this biological effect. This domain also has the potential for transcriptional activation, as shown in one-hybrid assays in mammalian cells. We further demonstrate that MLPs are multidomain proteins by showing a cis-negative effect of the N-terminal domain on the transactivation by the C-terminal domain and that the proline-rich, middle domain maximizes the activity of the C-terminal domain. We also mapped the MusMLP gene to a region on mouse chromosome 13 that corresponds to a region on human chromosome 5q that contains cancer-related genes. 0 1997 Elsevier Science Ireland Ltd. All rights reserved
Introduction
The transforming growth factor type fl (TGF-/3) family contains a growing number of structurally similar but functionally diverse polypeptides. Many ligands of this family, in particular TGF-OS, activins, decapentaplegic (dpp) and bone morphogenetic proteins (BMPs) have been shown to regulate growth, differentiation and activities (e.g. matrix deposition) of several cell types (reviewed by Kingsley, 1994; .
The functional receptor complexes for these ligands contain two cooperating type I and likely two type II serine/threonine kinase (STK) receptors. Both receptor types are essential for signal transduction (Wrana et al., 1992; Nellen et al., 1994; Ruberte et al., 1995; ten Dijke et al., 1996; Weis-Garcia and Massague, 1996) . The mechanism of receptor activation has been studied in detail for TGF-/3 and the basic features of this mechanism appear to be shared by the other ligand-receptor systems (Wrana et al., 1994; Liu et al., 1995; Ruberte et al., 1995; Wieser et al., 1995; . The family of STK receptors includes the mammalian type I and type II receptors for activin (ALK-2 and -4, respectively, and ActR-IIA and -IIB), BMPs (ALK-3, ALK-6 and BMPR-II) and TGF-0 (ALK-5 and TPR-II) (for a recent review, see ten Dijke et al., 1996) , and type I (&v and sax) and type II (punt) receptors for dpp in Drosophila (Brummel et al., 1994; Nellen et al., 1994; Penton et al., 1994; Xie et al., 1994; Letsou et al., 1995) . Binding and signaling properties of the known mammalian receptors have been studied extensively, and a complex picture is emerging where, e.g. ALK-2 may be a functional receptor for ligands of different subgroups in vivo, and can function with activin and BMP type II receptors (Rozenzweig et al., 1995; Yamashita et al., 1995) .
The expression patterns of components of the activin and BMP systems (ligands and receptors) during mouse embryogenesis have been studied in detail (Feijen et al., 1994; Dewulf et al., 1995; Lyons et al.. 1995; Verschueren et al., 1995) . These data, together with the mapping of naturally occurring mutations in the ligand genes, and gain-, and loss-of-function approaches for ligands and receptors in the vertebrate embryo, strongly support the important functions of these ligand-receptor systems in various processes in early (mesoderm formation in Xenopus: Green et al., 1992; Gurdon et al., 1994; Drosophila: Nellen et al., 1996) and late development (BMP7: Dudley et al., 1995 : Luo et al., 1995a ; ActR-IIA: Matzuk et al., 1995 ; Bmpr/ALK-3: Mishina et al., 1995; BMP4: Winnier et al., 1995; lefty and nodal: Collignon et al., 1996; Lowe et al., 1996; Meno et al., 1996) .
Relatively little is known about the signal transduction cascades that the receptors initiate. A combination of biochemical approaches.
yeast two-hybrid screening and homology cloning has been used to identify signaling components or substrates for STK activity. A p78 kinase 'and a novel MAPKKK (TAK-1) and its activator TAB-l have been implicated in TGF-6 and BMP4 signaling (Afti et al., 1995; Shibuya et al., 1996; Yamaguchi et al., 1995) . while the use of combinatorial peptide libraries has identified K$/TXXX as optimal substrates for STK activity of TPR-I and -11 (Luo et al., 1995b) . The immunophilin FKBP-12 and famesyl transferase alpha subunit can bind type I receptors (Wang et al., 1994 (Wang et al., , 1996a Kawabata et al., 1995) , and TRIP-l. a WD40 domain-containing protein, binds TPR-II (Chen et al., 1995) .
Genetic screens in Drosophila for maternal enhancers of weak alleles of dpp have allowed the identification of a novel locus, mothers against dpp (Mad), encoding a component of dpp pathways (Raftery et al., 1995; Sekelsky et al., 1995) . Mutations in Mad suppress phenotypes caused by ectopic expression of constitutively active tkv receptor in Drosophila, indicating that the protein functions downstream of the receptor (Hoodless et al., 1996) . Several groups, including ours, have recently cloned homologs of Mad. These include the sma genes in C. elegans, Xenopus (X) mad1 and -2. human dpc4 and MADRl (or Smadl) (Graff et al., 1996; Hahn et al., 1996; Hoodless et al., 1996; Liu et al., 1996; Savage et al., 1996 ; for a review, see MassaguC, 1996) . Overexpression of Xmadl and Mad (Newfeld et al., 1996) , and Xmad2 in animal caps results in the formation of ventral and dorsal mesoderm, respectively, thus mimicking a specific response to BMPY BMP4 and activin/nodal/Vgl, respectively (Graff et al.. 1996) . MADRl is phosphorylated and accumulates in the nucleus in response to BMP2 (Hoodless et al., 1996) . MADR 1 can function as a BMP-dependent transcriptional activator when fused to the DNA-binding domain of GAL4 (Liu et al., 1996) . Mad proteins are therefore proposed signal transducers for members of the TGF-/3 ligand and receptor families, and transcriptional activators that can specify distinct sets of signals elicited by different ligands.
In this paper, we report the cloning of two members of the emerging family, MusMLP and XenMLP (related to Xmadl). We have studied their expression patterns, and carried out structure-function studies with a large panel of XenMLP mutants in the Xenopus embryo as well as in one-hybrid assays, which demonstrate different functions of specific portions of this multidomain protein. In addition, we have mapped the MusMLP gene and a pseudogene to the mouse chromosome 13 and 6, respectively. The region on mouse chromosome 13 corresponds, in man, to a region that is subject to intensive searches for cancer-related genes.
Results

Cloning of a mouse homolog (MusMLP) of invertebrate Mad/Srna by' take-of PCR and isolatiorl of a Xenopus MLP (XenMLP) cDNA
To clone the cDNA of candidate vertebrate homologs (named MLPs. e.g. Mad-like proteins), we designed degenerate primers from protein sequence motifs which appeared conserved between Mad and the C. elegans sma genes, to use in PCRs on reverse transcribed mRNA isolated from mouse embryos (E15.5). Stringency variations, touchdown and nested approaches using different primers failed to produce specific amplification products. We therefore developed 'take-off' PCR. a method which combines linear PCR enrichments with nested PCR (for details, see Section 4). The nucleotide sequence of one specific 'take-off' PCR product, showed homology to the fruit fly and nematode Mads, and was used to design a nondegenerate primer. A combination of this primer with one degenerate primer yielded a new 1.2 kb fragment that encoded part of the MusMLP protein sequence. Screening of cDNA libraries from El 2.5 mouse embryos and Xenopus neurulae with this 1.2 kb fragment yielded clones encompassing the complete coding sequences of MusMLP and XenMLP. The recently published partial sequence of 58 amino acids of musDwarfin-C (Savage et al., 1996 ) matches our MusMLP. Graff et al. (1996) recently reported the isolation of two Xmad sequences starting from known EST sequences.
Their Xmadl protein sequence is very similar to our XenMLP (cloned from the neurula stage embryo), but there are minor differences (indicated in the legend to Fig. l) , like a 3 amino acid extension of the C-terminus of XenMLP. (Hoodless et al., 1996) . Mad (Raftery et al., 1995) and sma-2 (Savage et al.. 1996) . Black shading denotes identical residues, while gray indicates the conserved and white the non-conserved substitutions. Note the 3-domain structure with the conserved N-and C-terminal domains (underlined in white and black, respectively), and the variable middle and proline-rich domain (prolines in this domain in MusMLP are indicated by asterisks). The conserved charged, lysine-rich motif (KKLKKKK) in the N-terminal domain is outlined and indicated by arrowheads, and the PY and SPASS motifs are boxed. The sequence of XenMLP differs from Xmadl (Graff et al., 1996) at positions 60 (R + Q) and 261 (R --f Q). In addition, XenMLP has a different C-proximal sequence.
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Expression of MusMLP and XenMLP
Northern analysis of poly(A)-RNA isolated from adult mouse tissues and embryos showed that MusMLP transcripts are present in all investigated tissues and throughout postimplantation embryogenesis ( Fig. 2A) . A single and abundant 7.5 kb MusMLP transcript was detected, significantly exceeding the length of the 1.4 kb-long coding sequence, due to the presence of a long 5' leader sequence in the transcript (sequence data not shown).
In situ hybridization on sections of mouse embryos at different stages of development was carried out using 35S-labeled antisense RNA probes of MusMLP encompassing the so-called variable 'middle' domain (see below; Fig.  2B ), the full-size or the C-terminal domain (the results are identical for these three probes; data not shown), respectively, and using sense RNA as negative control (not shown). MusMLP is expressed throughout the E7.5-9.5 embryo (Fig. 2B ). This widespread expression persists at midgestation, and includes the developing nervous system and mesenchyme in precartilage condensations, premuscle masses and different organs of the gastro-intestinal and respiratory tracts. Elevated levels of MusMLP transcripts are present in mesenchymal cells lining the epithelial cells of the lung and, to a lesser extent, olfactory system, inner ear, developing teeth, stomach, and gut ( Fig. 2B) . High levels of expression were observed in the developing kidney (data not shown), splenic primordium and reproductive system (Fig. 2B) . The expression pattern of MusMLP during embryogenesis overlaps grossly with the combined patterns of two type I STK receptors, ALK-2 (ActR-IA) and ALK-3 (BMPR-IA) (Dewulf et al., 199.5; Verschueren et al., 1995) .
Northern blot analysis of Xenopus embryo RNA showed the presence of a 3 kb-long mRNA ( Fig. 2A) . Wholemount in situ hybridization in Xenopus gastrulae showed ubiquitous expression of XenMLP. (Fig. 2B ). In the tadpole, major expression was observed in the entire head region, brain, neural tube, notochord (data not shown) and the tail tip (Fig. 2B) . Both MusMLP and XenMLP thus have a uniform expression pattern during early embryogenesis, but particularly strong and localized expression is observed at later stages of development in both species. Fig. 1 shows the alignment of five Mad-like polypeptide sequences of different species that have recently been identified.
Mad-like proteins have a 3-domain structure
It includes MusMLP and XenMLP (this study), human MADRl (Hoodless et al., 1996) , Mad, and sma-2. The majority of Mad-like proteins are polypeptides of &450 amino acids with two conserved domains (the N-terminal domain and the C-terminal domain, also respectively called MHl and MH2, Hoodless et al., 1996) separated by a middle, proline-rich variable domain (Fig.  1 ). It is striking that the N-terminal domain of all known Mad-like proteins contains, besides a conserved lysinerich motif, other clusters of charged amino acids. This suggests ionic interaction with other molecules, perhaps MLPs themselves. The positive net charge of this domain (in MusMLP) makes nucleic acids and proteins with clusters of phosphorylated residues good candidates for interaction as well. Distinct short serine-rich and, to a lesser extent, threonine-rich stretches, likely substrates for STKs, can be found in the variable domain at the N-and C-terminus. The proline-rich variable domain could be part of a transactivation domain or involved in protein-protein interaction, although the protein does not appear to have sequences or predicted structures of known classes of DNA-binding proteins. Some, possibly fortuitous, patterns can be distinguished, however. The variable regions of MusMLP, XenMLP, MADRl, Mad (and Xmadl and Xmad2; Graff et al., 1996) contain a PY-like motif (PPPXY, with preference for PPPAY; Fig. 1 ) which has previously been identified to be involved in interaction of a sodium channel with a WW domain of a downstream effector (Staub et al., 1996) . The PY motif is preceded in some Mad members, by 2-3 copies of SPASS-like pattern(s). This pattern is also present in a proline/serine-rich region of a cytosolic component of transcription factor NF-AT in activated T-cells (Schreiber and Crabtree, 1992) . Sequence alignments thus suggest a 3-domain structure of Mad proteins. In addition, all known loss-of-function mutations in Mad, C. elegans sma-2, sma-3 and human dpc4 were mapped within a conserved segment in the Cterminal domain of the proteins (Raftery et al., 1995; Savage et al., 1996) .
XenMLP domain mutants studied in a GAIAdependent reporter assay in mammalian cells identlj) the C-terminal domain as a transcriptional activation domain
In order to analyze the function(s) of subdomains of Mad-like proteins, we constructed a large panel of Xen-MLP mutants based on the 3-domain protein model and the mapped mutations (Fig. 3) Error bars are standard deviations. Intra-assay variation in transfection efficiency is normalized on a cotransfected luciferase expression plasmid. MLP full-size and mutants are named as in Fig. 3 (D for deleted and aa for amino acids).
upstream of a minimal, TATA-box providing promoter of the fission yeast alcohol dehydrogenase gene (Remacle and Nelles, unpublished). Intra-assay variation in transfection efficiency was normalized by using a luciferaseencoding vector. Production and molecular mass of the hybrid proteins were verified in extracts of transfected COS cells by Western analysis using anti-GAL4 DBD antibodies. Only minute variations in production level of the GAL4-MLP fusion proteins were observed (data not shown).
The results of these experiments, carried out in HeLa cells, are shown in Fig. 4 . They were confirmed in MvlLu cells (mink lung epithelial cells, data not shown). In these systems, which use cells not stimulated by exogenous ligand, expression of full-size MLP reproducibly resulted in a very weak induction of LacZ reporter. Progressive removal of sequences from the N-terminal domain (mutants Dl-68 and Dl-119) of MLP never resulted in a significant increase of reporter expression. However, the MLP mutant that lacks the entire N-terminal domain (D l-145) had a very strong activity, dramatically higher than full-size MLP and the N-terminal domain truncations D l-68 and Dl-119.
This strongly suggests the presence of sequences in the N-terminal domain of XenMLP that are inhibitory to the transactivation activity of the GAL4-MLP hybrid proteins (see also D146-262 (inactive)). Our results also narrow this repressing activity down to the C-proximal 26 amino acids of this N-terminal domain (aa120-145).
The N-terminal domain of MLP (aal-145) itself lacked activity in this assay.
The C-terminal domain of MLP (Dl-262) transactivated to a very high level, but this level was consistently higher with mutant Dl-145, which contains the variable domain as well (Fig. 4) . Moreover, the variable region (aa146-262) had a weak but detectable transactivation activity that can apparently be repressed by the N-terminal domain (see D263-466, inactive) . This may indicate that a maximal activity of the MLP C-terminal domain involves some contribution from the variable domain. In addition, the results obtained with C-terminal domain deletion mutants D263-466 (inactive), D338-466 (inactive), and D424-466 (less than half the activity of the entire C-terminal domain) demonstrate further that the C-terminal domain of XenMLP can transactivate transcription in a GAL4 context.
Interpretations of domain interactions in this GAL4 DNA-binding domain context should be treated with caution. We nevertheless find that a consistent and interpretable pattern emerges from this one-hybrid approach: (i) the C-terminal domain of XenMLP has transcriptional transactivation potential, which can be (ii) increased by the proline-rich domain and (iii) repressed by the 26 Cproximal residues of the N-terminal domain in unstimulated cells; (iv) part of the C-terminal domain, residing around aa enables the repression by the N-terminal domain or, alternatively.
(iv') part of the C-terminal A.
B.
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Xvent-1 domain, residing between aa and aa is critical for the transactivation potential and another part, residing between aa and aa is necessary for maximal transactivation.
These experiments, carried out with an unprecedently large panel of MLP mutants, define XenMLP as a multidomain protein with the potential for transcriptional activation. To situate this observation in a biologically more relevant context, and to test the hypotheses formulated above, we decided to overexpress full length and deletion mutants of XenMLP in Xenupus embryos (i.e. in the presence of endogenous TGF-P-like ligands).
The C-terminal transactivation domain of XenMLP is both sufJicient and essential for causing ventralization in the Xenopus embryo
Functional studies with our cloned MLP sequences were carried out in the Xenopus embryo using in vitro made RNA encoding full-size XenMLP in a series of microinjections. Fig. 5A shows phenotypes of embryos radially microinjected with these RNAs into the equatorial region of 4-cell stage embryos. Overexpression of full length XenMLP caused loss of head structures and axial defects, as is typically observed for embryos ventralized by BMP4 (Dale et al., 1992; Jones et al., 1992) . This suggested that XenMLP is a component of the BMP ligand-receptor signaling system in early embryogenesis, as found recently for Xmadl (Graff et al., 1996) . Dorsal marginal zone explants from embryos microinjetted with RNA encoding XenMLP were analyzed by RT-PCR for modulation of the expression level of the ventral mesoderm marker Xvent-1 (Gawantka et al., 1995) . As shown in Fig. 5B , the expression of this marker gene is strongly induced by full-length XenMLP RNA.
To further elucidate the domain functions of MLPs in a biologically relevant assay, we microinjected RNA encoding the respective mutants or full-size MLP (as control) into Xenopus embryos and analyzed the phenotypes and Xvent-1 mRNA induction (Fig. 5) . The most important conclusions from this overexpression approach were that (i) while XenMLP ventralized the embryo, (ii) D424-466 (which is a C-terminally truncated XenMLP lacking 43 amino acids) and D263-466 (lacking the entire C-terminal domain, not shown) had no phenotypic effect, (iii) deletion of the N-terminal domain (Dl-145) did not affect the ventralized phenotype, and (iv) the C-terminal domain alone was sufficient to elicit the ventralization phenotype (not shown).
Qualitative analysis of expression of Xvent-1 by RT-PCR, using RNA from a series of microinjected embryos, showed that full size XenMLP induced Xvent-1. Removal of the N-terminal domain (Dl-145) still gave ventralization and induction of Xvent-1, while deletion of the Cterminal domain (D263-466) abolished induction (Fig.  5B) .
Taken together, our results show that overexpression of XenMLP mRNA leads to ventralization of dorsal mesoderm and that the C-terminal domain (sequence 264-466) is both necessary and sufficient for this effect in vivo. They complement our findings concerning a possible function in transcriptional activation for the C-terminal domain of Mad-like proteins.
Nuclear localization of the C-terminal domain of
XenMLP
The combination of in vivo effects together with the potential for transcriptional activation suggests a nuclear function for XenMLP. To further evaluate this we assayed for subcellular localization of tagged full length XenMLP and XenMLP domain mutants by indirect immunofluorescence. HA-tagged full size XenMLP, HA-tagged C-terminal domain (HAaa264-466) and HA-tagged XenMLP lacking the N-terminal domain (HAD1 -145) were overexpressed in COS cells using PCS-2 (Rupp et al., 1994) . Strong immunostainings were found in the nucleus for all three MLP fusions (Fig. 6 ) implying that MLP function has a nuclear component, probably defined by the C-terminal domain.
Genomic localization of mouse Mlpl
Using the 1.2 kb long cDNA clone of MusMLP as hybridization probe, Southern blot analysis of the DNAs of parental mice of the two genetic crosses identified BstEII fragments of 15.5 and 14.0 kb in NFS/N and C58/J and 23 and 9.7 kb in M. m. musculus. PstI digestion produced M. spretus fragments of 4.7, 2.7 and < 1.5 kb and, in NFS/N and C58/J, fragments of 4.4 and 2.9 kb. Analysis of both sets of progeny identified two unlinked loci identified by this probe (Fig. 7) . A single genetic locus was identified in the M. m. musculus cross; the 15.5 and 14.0 BstEII fragments were inherited together and mapped to a position on Chr 13 closely linked to 119. In the M. spretus cross, inheritance of 3 M. spretus PstI fragments were typed in the progeny of the Fl mated with C58/J, and to Chr 13 as did both of the NFS/N fragments of 4.4 and 2.9 kb. Combined data from the M. spretus and M. m. musculus crosses indicate that this locus, Mlpl, shows no recombination with 119 in 167 mice indicating that, at the upper limit of the 95% confidence level, these genes are within 1.78 CM. A second locus containing MAD related sequences was identified in the progeny of the cross (NFS/ N x M. spretus) x C58/J. The 2.7 kb PstI fragment of M. spretus mapped to Chr 6 distal to Ccnd2. Since this locus had no counterpart in the inbred strains NFS/N and C58/J, it is presumed to be a species specific pseudogene and is designated Mlpl -psi (Mad-like protein 1 -pseudogene 1). The location of the mouse Mlpl gene near 119 predicts that the human counterpart of this locus maps to 5q31-q35.
Discussion
We report in this paper the cloning of the full-size cDNA of one mouse MLP (matching 58 amino acids of MusDwarfin-C) by 'take-off' PCR, and one Xenupus luevis MLP from a cDNA library made from a neurula stage embryo. Our XenMLP described here is very similar but not identical to the recently reported Xmadl (Graff et al., 1996) , which may be due to the tetraploidy of the Xenopus genome. We discuss the expression pattern of both MLP genes in the respective embryos. In the mouse, MusMLP expression overlaps grossly with the combined expression patterns of ALK-2 and ALK-3 receptors (Dewulf et al., 1995; Verschueren et al., 1995) . Both of these receptors are expressed more widely in the embryo than their counterpart receptors ALK-4 (ActR-IB) and ALK-6 (BMPR-IB). For ALK4 and ALK-6, this includes epithelia of internal organs, while ALK-2 and ALK-3 are more mesenchymal.
BMPs (2 and 4) signal through ALK-3 and ALK-6 complexes containing the recently identified BMPR-II. However, ALK-2, ALK-3 and ALK-6 can signal for BMP7/0P-1 in a complex with either one of the activin type II receptors or BMPR-II (Yamashita et al., 1995; Rozenzweig et al., 1995) . Therefore, the expression pattern of MusMLP suggests it to be part of an ALK-2/ ALK-3 signaling pathway, presumably a BMP pathway. In the Xenopus, microinjections of BMP4 can elicit responses in all tested regions of the embryo (Koster et al., 1991; Dale et al., 1992; Jones et al., 1992) , suggesting that the BMP4 signaling pathway can be activated in most cells of the embryo. The ubiquitous expression of XenMLP is consistent with this observation.
MusMLP and XenMLP are members of the emerging family of polypeptides referred to as Mad (mothers against dpp), sma (from small body size mutants in C. elegans) or dwarfin family. These polypeptides are implicated in signaling by the TGF-/3 superfamily of ligands through their STK receptor complexes and are postreceptor, intracellular signaling components. Mad-like proteins have been shown to function by undergoing ligand-dependent serine phosphorylation and accumulation in the nucleus, and are proposed to act as transcriptional regulators (Hoodless et al., 1996; Liu et al., 1996) . We confirm with XenMLP other observations that some Mad members, including XenMLP, potently ventralize dorsal mesoderm and participate in BMP signaling in Xenopus (Graff et al., 1996) .
Using a large panel of XenMLP mutants in both the Xenopus embryo assay and a HeLa (and MvlLu) onehybrid assay, we have shown that biological and transactivation activity of XenMLP is strictly confined to its Cterminal domain, which is necessary and sufficient for these activities. These observations, combined with immunofluorescence data, lead to the conclusion that the Cterminal domain of XenMLP can act in the nucleus in a ligand-independent fashion upon overexpression. It can be anticipated that the C-terminal domain of Xmad2, a recently identified dorsalizing Mad protein (Graff et al., 1996) , also has this potential. During the time course of our studies, Baker and Harland (1996) have strengthened this assumption by showing dorsalizing activity of the C-terminal domain of mouse MADR2 in Xenopus embryos. All this implies that the target specificity of Mad protein activities relies on only very few amino acid differences in the conserved C-terminal domains.
We have found that the N-terminal domain exerts an inhibitory effect on the transactivator activity of the Cterminal domain in hybrids with GALLF-DBD. We also show that a C-terminal subdomain containing amino acid 424 is a likely target for this repression, which is probably exerted by a C-proximal part of the N-terminal domain. Ligand-dependent activation of Mad proteins (Liu et al., 1996) , perhaps by phosphorylation in the cytoplasm (Hoodless et al., 1996) , may alleviate an inhibitory activity of the N-terminal domain on the transcriptional activity of the C-terminal domain and/or result in a more efficient nuclear accumulation. The proline-rich domain that sepa-rates the N-from the C-terminal domain, and as we show can maximize transactivation activity of the C-terminal domain, may play an important role in these processes. One could envision a regulatory mechanism based on intramolecular interactions, similar to the model proposed for c-Myb activation (Dash et al., 1996) , in which phosphorylation induces 'unfolding' of the protein, thereby abolishing the inhibitory effect of the N-domain on the C-domain. The possible &-inhibitory activity of the Nterminal domain, as observed in the GAL4 assay, did not prevent biological effects in injected Xenopus embryos or nuclear accumulation in transfected COS cells. A plausible explanation could be that overexpression of full length XenMLP bypasses the requirement for activation in these systems.
To our knowledge, Mad-like sequences have not yet been identified in two-hybrid screens with receptor tails, or shown to interact with any of the other known receptorassociated polypeptides. This raises the possibility that the association of Mad proteins with STK receptors is transient and/or of very low affinity or, alternatively, that Madlike proteins are not direct substrates for the STK activity of the receptors. However, two-hybrid screens in yeast, using subdomains of Mad proteins may reveal whether the N-terminal domain and/or the variable domain interact with other polypeptides and/or Mad proteins, and lead to the identification of cofactors for the unmasked C-terminal transactivation domain of Mad proteins. In the absence of any convincing evidence for direct binding of Mad proteins to DNA, these cofactors may include transcription factors for immediate target genes for Mad action and ligand-responsive genes, like forkhead, goosecoid, Xvent and schnurri.
Loss-of-function alleles of Mad genes were identified by virtue of their phenotype and dpc4 has recently been identified as a pancreas-specific candidate tumor suppressor gene. One could argue that defects in signaling components, including Mad proteins, may be the direct cause of developmental phenotypes or allow cells to escape from the growth-suppressive and/or differentiation-inducing activities of TGF-/3 ligands. The mapping of MusMLP to a region of the mouse chromosome that is a candidate cancer region in the corresponding human chromosome 5q31-q35 allows us to test this assumption. This may provide the basis for further studies addressing the role of ligands, receptors and Mad proteins in development and disease.
Experimental procedures
PCR and cDNA library screening
Conventional degenerate RT-PCR methods to isolate cDNA fragments of a vertebrate homologue of Drosophila Mad failed because the reactions were swamped systematically by spurious, double stranded products. These were generated through non-specific annealing of only one of the two used primers to the 1st strand cDNA. We have therefore designed a method (see Fig. 8 ) that begins with linear enrichment for specific, single stranded, products using only one, reverse primer (primer 1, Fig. 8 ). One percent of this reaction is taken into a second round of linear PCR using another, forward primer (primer 2, Fig.  8 ). In both cases, reaction conditions are used that yield, in 30 cycles, a very faint smear but no discernible banding pattern after gel electrophoresis. Finally, a nested stringent PCR on the products of the second, linear PCR with primer 2 and another reverse primer (primer 3) can yield a specific double stranded product.
In order to clone MusMLP, primer I (CAYGTNATH-TAYTGYMG) was derived from the conserved amino acid sequence motif HVIYCR (H is aa 99 in Drosophila Mad). Primer 2 (TGDATYTCBATCCARCA) was derived from the amino acid sequence CWIEIH (C is aa 424 in Mad). Primer 3 (TGGGGNGCNGARTAYCA) was deduced from the sequence WGAEYH (W is aa 410 in Mad). The final, 59 bp long 'take-off' PCR product was cloned into pCR-Script (Stratagene) and sequenced.
A forward, non-degenerate primer 4 (CCAGCAGG-GAGTACTGG) was then derived from the sequence of the fragment obtained by 'take-off' PCR. This primer was used in combination with primer 5 (TGGAARCAG-GGVGAYGAGG) in a subsequent round of PCR. Primer 5 was derived from the amino acid sequence WKQGDEE (W is aa 34 in Mad) and from which infrequently used 3rd nucleotides in the codons were omitted (Wada et al., 1992) . This PCR yielded a single 1.2 kb-long DNA fragment that was cloned in pCR-Script (Stratagene). The sequence of the resulting clone (pMLP1.2) could be aligned with Mad sequences.
A combination of a screening of a randomly primed mouse cDNA library (E12.5) and 3' RACE-PCR (Gibco-BRL) on RNA from an El 2.5 mouse embryo produced the complete open reading frame (MusMLP). A screening of an oligo-dT primed cDNA library from Xenopus neurulae with the mouse MLPl.2 sequence at low stringency (65°C 4 x SSPE) yielded a 2 kb insert with a complete open
prmer z Fig. 8 . 
In situ hybridization
Mouse embryos were collected at 7.5, 8.5, 9.5, 12.5 and 15.5 pc. from CD1 mice. Sections were obtained as described previously (Dewulf et al., 1995) . Hybridization and autoradiography were carried out according to Wilkinson and Green (1990) with minor modifications (Verschueren et al., 1995) . RNA probes were prepared by in vitro transcription with phage T7 or T3 RNA polymerase. Antisense and sense full-size MusMLP probes were alkaline treated to an average length of 350 nucleotides. C-terminal MusMLP antisense probe was obtained by linearizing pMLP1.2 with HindIII, which cuts internally at two-thirds of the 1.2 kb-long insert. Proline-rich 'variable' domain MusMLP antisense probe was made of a subcloned 378 bp-long EcoRI-TaqI fragment.
HeLa and MvlLu (data not shown) and COS cells were grown in DMEM supplemented with 10% fetal bovine serum and non-essential amino acids. Subconfluent cells (in 10 cm* dishes) were transfected with a total of 5 BLg DNA (3 pg UASS-LacZ-plasmid (Remacle and Nelles, unpublished results), 1 pg pRSV/L (de Wet et al., 1987) , and 1 pg GALA-MLP fusion expression plasmid using DOTAP (Boehringer).
After 48 h, cell extracts were assayed for luciferase activity (Promega) and LacZ activity (Tropix).
To control expression of the GAL4 fusion constructs, COS cells were transiently transfected in 6 cm petri dishes, and cells were scraped after 48 h. Cells were lysed in SDS-PAGE sample buffer and proteins were analyzed by SDS polyacrylamide gel electrophoresis and western blotting using a monoclonal antibody against the GAL4 DNA binding domain (Santa Cruz) and an alkaline phosphatase conjugated secondary antibody.
Indirect immuojluorescence
Whole-mount in situ hybridization of Xenopus embryos was according to Harland (1991) with modifications (Gawantka et al., 1995) . All constructs were linearized and transcribed with SP6 RNA polymerase and a 5:l cap to GTP ratio. Radial injection refers to microinjection of all four blastomeres of 4-cell stage embryos into the equatorial region. In vitro fertilization, embryo culture, staging, microinjection and culture of marginal zone explants and animal caps were according to Niehrs and De Robertis (1991) .
Construction of XenMLP mutants (non-fused, GAL4 DBD domain fusions and HA tagging)
XenMLP domain mutants were generated by PCR using Pfu polymerase (Stratagene) and specific primers (with stop and start codons incorporated where appropriate). The amplified products were first cloned into pCRScript@ and subsequently subcloned into PCS-2 (Rupp et al., 1994) and pM-l (Sadowski et al., 1992) by means of EcoRI and XhoI restriction sites engineered to flank the 5' and 3' ends of the open reading frames, respectively. Deletion of the variable domain was obtained by amplifying the N-and C-terminal domains separately and ligating them together by means of a BglII site built into the PCR primers. Cloning of the products into the EcoRI and Sal1 sites of pM-1 resulted in in-frame fusions of the domain mutants with the GAL4 DBD. XenMLP domain mutants were HA-tagged at the amino terminus by insertion of an Indirect immunofluorescence was done on transiently transfected COS cells grown on chamber slides, 24 h after transfection. Cells were fixed for 10 min in 3% paraformaldehyde/PBS, washed 3 times for 5 min with PBS and subsequently permeabilized for 10 min in 0.5% Triton X-100. Blocking was done for 30 min with PBS containing 20% fetal bovine serum and 0.05% Tween-20. Incubation with monoclonal primary antibody against the HA tag (gift from C. DeVries, Amsterdam) (111000 dilution in PBS) was for 1 h. The slides were washed 3 times for 5 min in PBS and subsequently incubated with TRITC-labeled secondary antibodies (DAKO) (diluted l/l00 in PBS) for 1 h. Slides were washed as above and mounted using a water soluble mounting medium. To visualize the fluorescence, a Zeiss Axioskop microscope was used, equipped with the appropriate filters.
Genomic localization of MusMLP
Progeny of two sets of genetic crosses were tested: (NFS/N or C58/J x M. m. musculus) x M. m. musculus (Kozak et al., 1990) and (NFS/N X M. spretus) x M. spretus or C58/J (Adamson et al., 1991) . Progeny of these crosses have been typed for over 950 loci distributed over the 19 autosomes and the X chromosome. These loci include the Chr 6 loci Ccnd2 (cychn D2) and Kras-2 (Kirsten ras oncogene-2) which were typed as previously described (Tremblay et al., 1992) . The Chr 13 loci typed in these crosses included Hiv3pl (human immunodeficiency qf Development 61 (1997) [127] [128] [129] [130] virus enhancer binding protein l), 119 (interleukin 9), Dhfr (dihydrofolate reductase) and Cspg2 (chondroitin sulfate proteoglycan 2). Typing methods for Hivepl, 119, and Dhfr were described previously (Chakraborti and Kozak, 1992; Chong et al., 1995) . Cspg2 was typed in the M. m. musculus crosses following digestion with Sac1 and in the M. spretus crosses following BglII digestion using a mouse probe obtained from Dr. Y. Yamada (NIDR, Bethesda, MD). Recombinational distances were determined as described by Green (1981) .
Note added in revision
The gene locus name for MusMLP and its pseudogene is Mlpl and Mlpl-ps respectively, but will be changed by the appropriate Mouse Chromosome
Committee into madf and madl-ps. The sequences have been submitted to GenBank under names Smadl.1 (for XenMLP) and Smad5 (for MusMLP) according to the new nomenclature proposed by J. Massague (personal communication) .
Accession numbers are U77639 and U77638, respectively.
